Quadrant Capital Group’s Chemed CHE Stock Holding History

Quadrant Capital Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$762K	Buy	1,636 +1,296	+381%	+$545K	0.02%	698
2026 Q1	$128K	Sell	340 -131	-28%	-$56.1K	﹤0.01%	1409
2025 Q4	$202K	Sell	471 -789	-63%	-$343K	0.01%	1287
2025 Q3	$564K	Sell	1,260 -95	-7%	-$43K	0.02%	805
2025 Q2	$660K	Buy	1,355 +1,027	+313%	+$585K	0.02%	703
2025 Q1	$202K	Buy	328 +169	+106%	+$96.1K	0.01%	1292
2024 Q4	$84.2K	Sell	159 -39	-20%	-$22K	0.01%	1144
2024 Q3	$119K	Buy	198 +23	+13%	+$13K	0.01%	974
2024 Q2	$95K	Sell	175 -26	-13%	-$14.9K	0.01%	1046
2024 Q1	$129K	Sell	201 -5	-2%	-$3.04K	0.01%	862
2023 Q4	$120K	Buy	206 +51	+33%	+$28.5K	0.01%	886
2023 Q3	$80.6K	Sell	155 -27	-15%	-$14K	0.01%	1010
2023 Q2	$98.6K	Sell	182 -7	-4%	-$3.83K	0.01%	883
2023 Q1	$102K	Buy	189 +60	+47%	+$30.6K	0.01%	818
2022 Q4	$65.8K	Buy	129 +14	+12%	+$6.82K	0.01%	1005
2022 Q3	$50K	Buy	115 +26	+29%	+$12.5K	0.01%	1043
2022 Q2	$42K	Sell	89 -750	-89%	-$366K	0.01%	944
2022 Q1	$425K	Buy	839 +790	+1,612%	+$379K	0.05%	253
2021 Q4	$26K	Sell	49 -21	-30%	-$10.1K	﹤0.01%	1182
2021 Q3	$33K	Buy	70 +21	+43%	+$9.9K	﹤0.01%	1023
2021 Q2	$23K	Sell	49 -12	-20%	-$5.76K	﹤0.01%	1138
2021 Q1	$28K	Buy	61 +13	+27%	+$6.37K	﹤0.01%	1026
2020 Q4	$26K	Buy	48 +8	+20%	+$3.93K	﹤0.01%	989
2020 Q3	$19K	Sell	40 -225	-85%	-$110K	﹤0.01%	971
2020 Q2	$120K	Buy	265 +162	+157%	+$72.3K	0.03%	395
2020 Q1	$44K	Buy	103 +9	+10%	+$4.02K	0.01%	934
2019 Q4	$38K	Hold	94	–	–	﹤0.01%	1460
2019 Q3	$37K	Hold	94	–	–	0.01%	1343
2019 Q2	$33K	Hold	94	–	–	0.01%	1388
2019 Q1	$26K	Buy	94 +61	+185%	+$18.7K	﹤0.01%	1446
2018 Q4	$7K	Hold	33	–	–	﹤0.01%	1503
2018 Q3	$7K	Hold	33	–	–	﹤0.01%	1420
2018 Q2	$7K	Hold	33	–	–	﹤0.01%	1420
2018 Q1	$7K	Hold	33	–	–	﹤0.01%	1408
2017 Q4	$6K	Sell	33 -62	-65%	-$14.1K	﹤0.01%	1400
2017 Q3	$17K	Buy	95 +9	+10%	+$1.77K	0.01%	970
2017 Q2	$15K	Hold	86	–	–	0.01%	953
2017 Q1	$14K	Buy	86 +15	+21%	+$2.62K	0.01%	955
2016 Q4	$9K	Sell	71 -6	-8%	-$881	﹤0.01%	1051
2016 Q3	$9K	Buy	77 +15	+24%	+$2.09K	0.01%	1080
2016 Q2	$8K	Sell	62 -20	-24%	-$2.65K	0.01%	1079
2016 Q1	$10K	Buy	82 +12	+17%	+$1.62K	0.01%	950
2015 Q4	$10K	Sell	70 -375	-84%	-$55.4K	0.01%	788
2015 Q3	$59K	Sell	445 -5	-1%	-$700	0.04%	363
2015 Q2	$58K	Buy	+450	New	+$55.7K	0.04%	390

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Quadrant Capital Group's CHE Position: Q2 2026 in Review

Quadrant Capital Group increased its Chemed (CHE) stake by 381% in Q2 2026, buying an estimated $545K and bringing the position to 1,636 shares worth $762K. The position accounts for 0.02% of the portfolio, ranked #698.

Quadrant Capital Group first reported a position in CHE in Q2 2015 and has held it in 45 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Quadrant Capital Group held 1,636 shares of Chemed worth $762K as of Q2 2026.
Quadrant Capital Group bought 1,296 Chemed shares in Q2 2026, an estimated $545K.
Chemed made up 0.02% of Quadrant Capital Group's portfolio in Q2 2026, its #698 holding.
Quadrant Capital Group first reported a position in Chemed in Q2 2015 and has held it in 45 quarters since.
530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.